P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth

被引:47
|
作者
He, Hong [1 ]
Nhi Huynh [1 ]
Liu, Kevin H. [1 ]
Malcontenti-Wilson, Cathy [1 ]
Zhu, Jin [2 ,3 ]
Christophi, Christopher [1 ]
Shulkes, Arthur [1 ]
Baldwin, Graham S. [1 ]
机构
[1] Univ Melbourne, Dept Surg, Austin Hlth, Melbourne, Vic 3084, Australia
[2] Third Mil Med Univ, Southwest Hosp, Chongqing 400038, Peoples R China
[3] Third Mil Med Univ, Inst Hepatobiliary Surg, Chongqing 400038, Peoples R China
基金
英国医学研究理事会;
关键词
PAK1; beta-Catenin; CRC; P21-ACTIVATED KINASES; COLON-CANCER; MUTATIONS; RAS; APC; PROGRESSION; METASTASIS; PROTEIN; KRAS; WNT;
D O I
10.1016/j.canlet.2011.11.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p21-activated kinase 1 (PAK1) plays important roles in cell growth, motility, and transformation. The aims of this study were to delineate the signalling mechanisms downstream of PAK1, and to investigate the importance of PAK1 for colorectal cancer (CRC) growth and metastasis in vivo. PAK1 knockdown in human CRC cell lines inhibited beta-catenin expression, beta-catenin/TCF4 transcriptional activity, and the expression of c-Myc. In mouse models PAK1 knockdown suppressed the growth and metastasis of human CRC cells by decreasing proliferation and increasing apoptosis. Our findings demonstrate for the first time the crucial role of PAK1 in CRC progression in vivo. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 50 条
  • [1] P-21 activated kinase 1 knockdown blocks growth and metastasis of colorectal cancer via inhibition of beta-catenin signalling
    Baldwin, G. S.
    He, H.
    Huynh, N.
    Liu, K. H.
    Malcontenti-Wilson, C.
    Zhu, J.
    Christophi, C.
    Shulkes, A.
    Baldwin, G. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 131 - 131
  • [2] Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1α and β-catenin via a p-21 activated kinase 1-dependent pathway
    Nhi Huynh
    Beutler, John A.
    Shulkes, Arthur
    Baldwin, Graham S.
    He, Hong
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (01): : 157 - 165
  • [3] Knockdown of p21-activated Kinase 6 Inhibits Prostate Cancer Growth and Enhances Chemosensitivity to Docetaxel
    Wen, Xingqiao
    Li, Xiaojuan
    Liao, Bing
    Liu, Yong
    Wu, Jieying
    Yuan, Xiaoxu
    Ouyang, Bin
    Sun, Qipeng
    Gao, Xin
    UROLOGY, 2009, 73 (06) : 1407 - 1411
  • [4] KNOCKDOWN OF P21-ACTIVATED KINASE 6 INHIBITS PROSTATE CANCER GROWTH AND ENHANCES CHEMOSENSITIVITY TO DOCETAXEL
    Wen, Xingqiao
    Li, Xiaojuan
    Ye, Chunwei
    Zhu, Baoyi
    Gao, Xin
    JOURNAL OF UROLOGY, 2011, 185 (04): : E166 - E166
  • [5] KNOCKDOWN OF P21-ACTIVATED KINASE 6 INHIBITS PROSTATE CANCER GROWTH AND ENHANCES CHEMOSENSITIVITY TO DOCETAXEL
    Wen, Xingqiao
    Li, Xiaojuan
    Wang, Yu
    Wu, Jieying
    Gao, Xin
    JOURNAL OF UROLOGY, 2010, 183 (04): : E153 - E153
  • [6] Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway
    Yang, Yang
    Nhi Huynh
    Dumesny, Chelsea
    Wang, Kai
    He, Hong
    Nikfarjam, Mehrdad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 11
  • [7] p-21 Activated Kinase as a Molecular Target for Chemoprevention in Diabetes
    Dammann, Kyle
    Khare, Vineeta
    Coleman, Clyde
    Berdel, Henrik
    Gasche, Christoph
    GERIATRICS, 2018, 3 (04)
  • [8] Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1
    Khare, Vineeta
    Lyakhovich, Alex
    Dammann, Kyle
    Lang, Michaela
    Borgmann, Melanie
    Tichy, Boris
    Pospisilova, Sarka
    Luciani, Gloria
    Campregher, Christoph
    Evstatiev, Rayko
    Pflueger, Maren
    Hundsberger, Harald
    Gasche, Christoph
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (02) : 234 - 244
  • [9] p-21 activated kinase 4 (PAK4) role in pancreatic cancer stem cells
    Herreros-Villanueva, Marta
    Bujanda, Luis
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S335 - S337
  • [10] Regulation of p-21 activated kinase by angiotensin II through Rho/Rho kinase pathway
    Woolfolk, E
    Eguchi, S
    Motley, ED
    FASEB JOURNAL, 2004, 18 (04): : A308 - A308